Conflicts of Interest
No author has a relevant conflict of interest. DTT serves on advisory boards for Janssen, Amgen, La Roche, Sobi, and Humanigen. HB has stock ownership in CSL Behring. SH serves on the advisory board for Horizon Pharma. AOJ serves on the advisory board of Pluton Biosciences. MPL is an advisory board member for Octapharma, Novartis, Aregenix, and Shionogi, a consultant for Amgen, Novartis, Shionogi, Dova, Bayer, and has received research funding from Sysmex, Novartis, and Astra Zeneca. KES received personal fees from Elsevier and Immune Deficiency Foundation. SEH has received consultancy fee from Sanofi Pasteur, Lumen, Novavax, and Merck for work unrelated to this report.